Using economic evidence in clinical practice

Journal of Medical Practice Management

Volumn 17, Issue 5, 2002, Pages 272-277

  Stone, Patricia W ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cost effectiveness; Cost utility; Evidence based practice; Quality adjusted life year (QALY)

Indexed keywords

CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH ECONOMICS; REVIEW; STANDARD;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE MANAGEMENT, MEDICAL; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 0036122078     PISSN: 87550229     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Health spending growth up in 1999; faster growth expected in the future
2. Management of patients with Bacilli Calrnette-Guerin-refractory carcinoma in situ of the urinary bladder: Cost implications of a clinical trial for valrubicin
3. One thousand health-related quality-of-life estimates
4. Gains in life expectancy from medical interventions-standardizing data on outcomes
5. Evaluating the cost-effectiveness of clinical and public health measures
6. Variation among quality-of-life surveys. Theory and practice
7. Estimating general-population utilities using one binary-gamble question per respondent
8. Measuring preferences for health states worse than death
9. Measuring health and health state preferences among critically ill patients
10. Evaluating quality-of-life and health status instruments: Development of scientific review criteria
11. An off-the-shelf help list: A comprehensive catalog of preference scores from published cost-utility analyses
12. The beaver dam health outcomes study: Initial catalog of health-state quality factors
13. The quality of reporting in published cost-utility analyses, 1976-1997
14. A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies
15. Cost-utility analyses of clinical preventive services: Published ratios, 1976-1997
16. A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example
17. On valuing morbidity, cost-effectiveness analysis, and being rude
18. Valuing health care benefits in money terms
19. Health care CBA and CEA from 1991 to 1996: An updated bibliography
20. Estimating costs in the economic evaluation of medical technologies
21. Measuring costs in cost-utility analyses. Variations in the literature
22. How to calculate indirect costs in economic evaluations
23. How to calculate indirect costs in economic evaluations
24. Costing medical care: Using Medicare administrative data
25. Recommendations for reporting cost-effectiveness analyses
26. Recommendations of the panel on cost-effectiveness in health and medicine
27. The role of cost-effectiveness analysis in health and medicine
28. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine
29. Guidelines for authors and peer reviewers of economic submissions to the BMJ
30. Users' guides to the medical literature XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients?
31. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid?
32. Getting evidence into practice: The work of the Cochrane Effective Practice and Organization of care Group EPOC
33. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services
34. Current methods of the U.S. Preventive Services Task Force. A review of the process
35. Cost-utility analyses of clinical preventive services: Published ratios, 1976-1997
36. A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies
37. The quality of reporting in published cost-utility analyses, 1976-1997
38. Systematic overview of cost-utility assessments in oncology
39. QALY league tables: Handle with care
40. Some guidelines on the use of cost effectiveness league tables
41. Raising the quality of cost-utility analyses: Lessons learnt and still to learn